These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Biological conversions of agroclavine and elymoclavine. Tyler VE; Erge D; Gröger D Planta Med; 1965 Aug; 13(3):316-25. PubMed ID: 5826183 [No Abstract] [Full Text] [Related]
34. Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry. Lehner AF; Craig M; Fannin N; Bush L; Tobin T J Mass Spectrom; 2004 Nov; 39(11):1275-86. PubMed ID: 15470699 [TBL] [Abstract][Full Text] [Related]
35. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors. Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE J Neurosci Res; 1983; 10(2):175-89. PubMed ID: 6313954 [TBL] [Abstract][Full Text] [Related]
36. [The development of ergot alkaloids as drugs]. Sinz A Pharm Unserer Zeit; 2008; 37(4):306-9. PubMed ID: 18618815 [No Abstract] [Full Text] [Related]
37. [Effects of clavines, ergot alkaloids, on the membrane potential of an identifiable giant neuron of the African giant snail Achatina fulica Ferussac]. Miyamoto M; Tamura H; Takeuchi H; Endo I C R Seances Soc Biol Fil; 1980; 174(3):290-6. PubMed ID: 6448672 [TBL] [Abstract][Full Text] [Related]
38. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine. Horowski R Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013 [No Abstract] [Full Text] [Related]
39. [Natural and semisynthetic alkaloids of rye ergot]. Boismare F LARC Med; 1981 Oct; 1(1):54, 57-8. PubMed ID: 7349678 [No Abstract] [Full Text] [Related]
40. Progress in the medicinal chemistry of dopaminergic agents. Schaus JM; Kornfeld EC; Titus RD; Nichols CL; Huser DL; Clemens JA; Smalstig EB; Fuller RW Drug Des Discov; 1993; 9(3-4):323-32. PubMed ID: 8104521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]